The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for ripretinib (Tudorrose Consulting Pty Ltd)
Active ingredients
ripretinib
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Tablet
Indication
For the treatment of gastrointestinal stromal tumours (GIST)
Therapeutic area
Oncology